Lisata Therapeutics announces retirement of director Erkki Ruoslahti; remains advisor

LISATA THERAPEUTICS, INC.

Dr. Erkki Ruoslahti resigned from the Board of Directors effective July 11, 2023.
He will continue as a scientific advisor to the Company.
Ruoslahti cited confidence in LSTA1 progress and reduced international travel as reasons.
He is the scientific founder of the CendR Platform and a Lasker Prize winner.
No replacement announced; board size unchanged.

item 5.02 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

Erkki Ruoslahti

Director

LSTA · LISATA THERAPEUTICS, INC.

Effective: 2023-07-11
Filed: July 11, 2023, 7:59 PM ET

Lisata Therapeutics, Inc. (the “Company”) today announced that Erkki Ruoslahti, M.D., Ph.D., has decided to retire from its Board of Directors effective today, July 11, 2023.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Erkki Ruoslahti retired as Director at LISATA THERAPEUTICS, INC..

Action: retired
Role: Director

Exact text from the filing

Lisata Therapeutics, Inc. (the “Company”) today announced that Erkki Ruoslahti, M.D., Ph.D., has decided to retire from its Board of Directors effective today, July 11, 2023.

View on SEC.gov

LISATA THERAPEUTICS, INC. filing history →

Source: SEC EDGAR

accession 0000320017-23-000037

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.